2022
DOI: 10.1007/s10072-022-06283-6
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous thrombolysis before mechanical thrombectomy for acute ischemic stroke due to large vessel occlusion; should we cross that bridge? A systematic review and meta-analysis of 36,123 patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(5 citation statements)
references
References 66 publications
0
5
0
Order By: Relevance
“…This difference may be explained considering the improvement of long-term functional outcomes of ischemic stroke over the last five years due to intravenous thrombolysis and endovascular treatments for large vessel occlusion. 30 …”
Section: Discussionmentioning
confidence: 99%
“…This difference may be explained considering the improvement of long-term functional outcomes of ischemic stroke over the last five years due to intravenous thrombolysis and endovascular treatments for large vessel occlusion. 30 …”
Section: Discussionmentioning
confidence: 99%
“…In the light of inconclusive observations on the effect of bridging IVT for acLVO on functional outcome from several RCTs and meta-analyses [3][4][5][6][7][8][9]15 , recent research focused on deeper exploration of patient and treatment-related characteristics that might modulate this effect. A retrospective analysis of the International Stroke Perfusion Imaging Registry (n=323) suggested that bridging IVT (n=241) is beneficial in patients with fast growing infarct core due to more rapid completion of thrombectomy resulting in a reduced final size of the ischemic lesion.…”
Section: Discussionmentioning
confidence: 99%
“…[3][4][5][6] The latter observation was recently supported by a meta-analysis of clinical trials and observational studies that synthesized data from 36,123 patients and found slightly improved functional outcome and reperfusion rates in thrombectomy patients who also received bridging IVT. 7 Moreover, the open-label, blinded-endpoint, randomized trials SWIFT-DIRECT and DIRECT-SAFE failed to show non-inferiority of omitting bridging IVT before thrombectomy and even found effect directions in favor of bridging IVT. 8,9 Consequentially, the question whether bridging IVT adds value to thrombectomy beyond non-inferiority continues to be a topic of exploration.…”
Section: Introductionmentioning
confidence: 99%
“…Current IS treatment relies entirely on reperfusion therapy, including thrombolysis and thrombectomy. Thrombolysis is mainly administered with recombinant tissue plasminogen activator (rt-PA) or other proteins with similar activity ( Crocker et al, 2021 ; Faizy et al, 2022 ), whereas thrombectomy is primarily endovascular treatment (EVT) and mechanical thrombectomy ( Herpich and Rincon, 2020 ; Ghaith et al, 2022 ). However, due to the highly limited time window and the risk of hemorrhagic events, t-PA can only be used in less than 10% of patients with stroke and with less than 50% achieving success ( Rha and Saver, 2007 ; Peña-Martínez et al, 2022 ).…”
Section: Introductionmentioning
confidence: 99%